NewsfeedFollowed Companies

Abiomed's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Abiomed provides temporary percutaneous mechanical circulatory support devices and offers a continuum of care to heart f... Read more

Based on data from Abiomed's latest SEC filings

Annual Revenue

Based on data from Abiomed's latest SEC filings

Employees

Michael R. Minogue's photo - Chairman & CEO of Abiomed

Chairman & CEO

Michael R. Minogue

CEO Approval Rating

96/100

OVERVIEW

Founded:

1981

Headquarters:

DanversMassachusetts

Status:

PublicIndependent Company of NASDAQABMD

Industry Sector:

- -

SIC Code:

8000NAICS listing »

5047NAICS listing »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Organox a competitor of Abiomed?

I don't know

Trending News for Abiomed and Abiomed's Competitors

Today 3:52 AM

BioPortfolio

Abiomed Inc ABMD Product Pipeline Analysis 2019 Update Published by Global Data Prices from USD $660

SummaryAbiomed Inc Abiomed provides mechanical circulatory support devices and develops manufactures ... See more »

December 4, 2019

Becker's Spine Review

Medtronic, Lumeon partner for value-based care platform in Europe

Medtronic and Lumeon entered into a strategic partnership that aims to help healthcare providers in E... See more »

December 5, 2019

Zacks

Boston Scientific's Watchman Implant Study Results Encourage

These study results are expected to be a major breakthrough for Boston Scientific's (BSX) Cardiovascu... See more »

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

HeartWare is seen as one of Abiomed's biggest rivals. HeartWare was founded in 1995 in Framingham, Massachusetts. HeartWare operates in the Health Care Equipment industry. HeartWare generates $557.8M less revenue than Abiomed.

Thoratec is one of Abiomed's top competitors. Thoratec was founded in 1976, and its headquarters is in Pleasanton, California. Thoratec operates in the Health Care Supplies industry. Thoratec has 95 fewer employees than Abiomed.

Conformis is one of Abiomed's top rivals. Conformis was founded in 2004, and is headquartered in Billerica, Massachusetts. Conformis is in the Health Care Equipment field. Conformis generates $740.7M less revenue vs. Abiomed.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Michael R. Minogue

Chairman & CEO

- -
1,143
$42.1M
$820.3M
1

CEO

- -
625
$234.3M
$262.5M
2

D. Keith Grossman

President & CEO

67/100
1,048
$50M
$473.9M
3

Mark Augusti

President & CEO

83/100
380
$693.9M
$79.6M
4

John P. Groetelaars

President & CEO

79/100
10,000
- -
$2.9B
5

Don Webber

CEO

80/100
70
$43M
$67.5M
6

Les Russell

CEO

69/100
98
- -
$9.3M
7

Jeffrey M. Soinski

President & CEO

54/100
197
$291M
$8.6M
8

Rick Geoffrion

President & CEO

74/100
40
$66.5M
$4M
9

CEO

- -
2,050
- -
$500M
10

Omar Ishrak

Chairman & CEO

84/100
86,000
- -
$30.7B
The top 10 competitors in Abiomed's competitive set are HeartWare, Thoratec , Conformis, Hill-Rom, SynCardia, Organox, Avinger, Mitralign, MAQUET and Medtronic. Together they have raised over 1.4B between their estimated 104.3K employees. Abiomed has 1,143 employees and is ranked 4th among it's top 10 competitors. The top 10 competitors average 9,241.

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$820.3M

Abiomed's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 3.3B. Over the last four quarters, Abiomed's revenue has grown by 2.2%. Specifically, in Q3 2019's revenue was $205M; in Q2 2019, it was $207.7M; in Q1 2019, it was $207.1M; in Q4 2018, Abiomed's revenue was $200.6M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

-

Jun 2014

Source »
$30M
-

These are all the companies that Abiomed has acquired. Abiomed's latest acquisition was in Jun 2014.

Abiomed Funding History

Since Abiomed was founded in 1981, it has participated in 1 round of funding. In total Abiomed has raised $42.1M. Abiomed's funding round was on Aug 2008 for a total of $42.1M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Aug 2008
$42.1M

Total Funding: $42.1M

Since Abiomed was founded in 1981, it has participated in 1 round of funding. In total Abiomed has raised $42.1M. Abiomed's funding round was on Aug 2008 for a total of $42.1M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Impulse Dynamics is a medical device company that develops cardiac contractility modulation therapy for the treatment of chronic heart failure.
$80.3M
Dec 02, 2019
Series D
-
Protembis designs and develops cerebral protection systems for transcatheter aortic valve replacement surgery procedures.
$10M
Oct 25, 2018
Series A
-
RenalGuard develops Contrast-Induced Nephropathy for the cardiovascular treatment.
$7M
Sep 13, 2018
Equity
-
Reprieve Cardiovascular designs and manufactures medical devices for the treatment of patients suffering from acute decompensated heart failure.
$7M
Sep 11, 2018
Equity
-
Magenta Medical is a manufacturer of balloon catheter device for the treatment of acute and chronic heart failure.
$15M
Sep 28, 2017
Unattributed
-

These are all the companies that Abiomed has invested in. Abiomed's latest investment was in Jun 2014.

Abiomed News

November 27, 2019BioPortfolio

Abiomed to Present at the 31st Annual Piper Jaffray Healthcare Conference

Abiomed Inc. NASDAQABMD a leading provider of breakthrough heart support technologies today announced... See more »
November 19, 2019BioPortfolio

Abiomed Medical Office Completes Review of Observational Analysis of Impella Presented at AHA

Abiomed NASDAQ ABMD is committed to improving patient outcomes by performing FDA studies and postmark... See more »
November 19, 2019Seeking Alpha

Abiomed defends Impella after critical study; shares ahead 5%

See more »
November 5, 2019DirectorsTalk Interviews

ABIOMED, Inc. - Consenus Indicates Potential 14.5% Upside

ABIOMED, Inc. with ticker code (ABMD) have now 6 analysts covering the stock. The analyst consensus p... See more »
November 4, 2019Seeking Alpha

Another Quarter Of Jaw-Dropping Margins And Cash Flow Generation

See more »
November 4, 2019Seeking Alpha

Abiomed, Inc. 2020 Q2 - Results - Earnings Call Presentation

See more »
November 1, 2019BioPortfolio

First US patients treated with Impella 5.5 with SmartAssist

Three cardiac surgeons at Cleveland Clinic Hackensack Meridian Health and CedarsSinai Medical Center ... See more »

Abiomed Press Releases

August 31, 2019GlobalNewswire

ROSEN, A HIGHLY RANKED LAW FIRM, Reminds Abiomed, Inc. Investors of Important Deadline in Securities Class Action - ABMD

NEW YORK, Aug. 31, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, remind... See more »
January 10, 2019StreetInsider

Abiomed Third Quarter Fiscal 2019 Earnings and Conference Call Notification

Abiomed, Inc. (NASDAQ: ABMD) announced that on Thursday, January 31, 2019, the company will release f... See more »
November 2, 2018StreetInsider

Abiomed to Present at the Stephens 2018 Investment Conference in New York, NY

Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today an... See more »
September 24, 2018GlobeNewswire

Data Presented at TCT 2018 Shows Use of Impella and Best Practices Increases Cardiogenic Shock Survival

SAN DIEGO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- A new analysis of data from Abiomed's (NASDAQ:ABMD) Imp... See more »
September 12, 2018Business Wire

RenalGuard Solutions Debuts Newly Formed Reprieve Cardiovascular at Heart Failure Society of America Annual Meeting and Completes $7 Million Financing

MILFORD, Mass.--(BUSINESS WIRE)--Reprieve Cardiovascular , a newly formed company affiliated with Ren... See more »
August 2, 2018Business Wire

Global Cardiac Rhythm Management Devices Market Segmented by Product Type & Geography - Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 4.8% - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Cardiac Rhythm Management Devices Market - Segmented by Product ... See more »
October 13, 2017Business Wire

Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2017 - Research and Markets

DUBLIN--(BUSINESS WIRE)--The "Ventricular Assist Devices - Medical Devices Pipeline Assessment, 2017"... See more »

Abiomed Videos

September 27, 2019Abiomed Youtube Channel

"The Value of Complete Revascularization" on YOUTUBE

See more »
September 12, 2019Abiomed Youtube Channel

"Hilton Head Regional Healthcare Heart Recovery Reunion" on YOUTUBE

See more »
August 13, 2019Abiomed Youtube Channel

"North Oaks Medical Center Heart Recovery Reunion" on YOUTUBE

See more »
August 12, 2019Abiomed Youtube Channel

"2019 Patient Summit" on YOUTUBE

See more »
August 9, 2019Abiomed Youtube Channel

"Alternative Access - Critical Skills for Advanced Interventional Operators" on YOUTUBE

See more »
August 7, 2019Abiomed Youtube Channel

"Abiomed Four Guiding Principles" on YOUTUBE

See more »
July 10, 2019Abiomed Youtube Channel

"ProtectedPCI TV commercial" on YOUTUBE

See more »

Social Statistics

Headquarters

22 Cherry Hill Dr

Danvers, Massachusetts01923

978-646-1400

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Abiomed provides temporary percutaneous mechanical circulatory support devices and offers a continuum of care to heart failure patients.  Abiomed was founded in 1981. Abiomed's headquarters is located in Danvers, Massachusetts, USA 01923. It has raise...

CEO

Abiomed's Chairman & CEO, Michael R. Minogue, currently has an approval rating of 96%. Abiomed's primary competitors are HeartWare, Thoratec & Conformis.

Website

abiomed.com

Frequently Asked Questions about Abiomed

  1. When was Abiomed founded?

    Abiomed was founded in 1981

  2. Who is Abiomed's CEO?

    Abiomed's CEO is Michael R. Minogue

  3. How much revenue does Abiomed generate?

    Abiomed generates $820.3M in revenue

  4. How much funding does Abiomed have?

    Abiomed has historically raised $42.1M in funding

  1. Where is Abiomed's headquarters?

    Abiomed's headquarters is in Danvers Massachusetts, USA

  2. How many employees does Abiomed have?

    Abiomed has 1,143 employees

  3. Who are Abiomed's competitors?

    Abiomed's top competitors are HeartWare, Thoratec , Conformis

  4. Who has Abiomed invested in?

    Abiomed's has invested in companies such as Impulse Dynamics, Protembis, RenalGuard
Stay up-to-date with the latest news on Abiomed